# Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

> **NCT06313749** · NA · RECRUITING · sponsor: **Sanoculis Ltd** · enrollment: 129 (estimated)

## Conditions studied

- Primary Open Angle Glaucoma
- Open Angle Glaucoma

## Interventions

- **DEVICE:** Minimally Invasive Micro Sclerostomy Device

## Key facts

- **NCT ID:** NCT06313749
- **Lead sponsor:** Sanoculis Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06313749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06313749, "Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06313749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*